Detecting bacterial lung infections: in vivo evaluation of in vitro volatile fingerprints

The identification of bacteria by their volatilomes is of interest to many scientists and clinicians as it holds the promise of diagnosing infections in situ, particularly lung infections via breath analysis. While there are many studies reporting various bacterial volatile biomarkers or fingerprints using in vitro experiments, it has proven difficult to translate these data to in vivo breath analyses. Therefore, we aimed to create secondary electrospray ionization-mass spectrometry (SESI-MS) pathogen fingerprints directly from the breath of mice with lung infections. In this study we demonstrated that SESI-MS is capable of differentiating infected versus uninfected mice, P. aeruginosa-infected versus S. aureus-infected mice, as well as distinguish between infections caused by P. aeruginosa strains PAO1 versus FRD1, with statistical significance (p < 0.05). In addition, we compared in vitro and in vivo volatiles and observed that only 25-34% of peaks are shared between the in vitro and in vivo SESI-MS fingerprints. To the best of our knowledge, these are the first breath volatiles measured for P. aeruginosa PAO1, FRD1, and S. aureus RN450, and the first comparison of in vivo and in vitro volatile profiles from the same strains using the murine infection model.

[1]  B. Holloway.  Genetic recombination in Pseudomonas aeruginosa. , 1955, Journal of general microbiology.

[2]  Deborah A Hogan,et al.  Hemolytic phospholipase C inhibition protects lung function during Pseudomonas aeruginosa infection. , 2011, American journal of respiratory and critical care medicine.

[3]  Panagiotis Artemiadis,et al.  A hybrid BMI-based exoskeleton for paresis: EMG control for assisting arm movements , 2017, Journal of neural engineering.

[4]  R H Dainty,et al.  Volatile compounds associated with the aerobic growth of some Pseudomonas species on beef. , 1984, The Journal of applied bacteriology.

[5]  Alphus D. Wilson,et al.  Advances in Electronic-Nose Technologies Developed for Biomedical Applications , 2011, Sensors.

[6]  Patrik Španěl,et al.  Direct, rapid quantitative analyses of BVOCs using SIFT-MS and PTR-MS obviating sample collection , 2011 .

[7]  David R Murdoch,et al.  The rapid evaluation of bacterial growth and antibiotic susceptibility in blood cultures by selected ion flow tube mass spectrometry. , 2006, Diagnostic microbiology and infectious disease.

[8]  S. Akira,et al.  Th2 allergic immune response to inhaled fungal antigens is modulated by TLR‐4‐independent bacterial products , 2009, European journal of immunology.

[9]  P. Martínez-Lozano,et al.  On-line detection of human skin vapors , 2009, Journal of the American Society for Mass Spectrometry.

[10]  C. D. Cox,et al.  Use of 2-aminoacetophenone production in identification of Pseudomonas aeruginosa , 1979, Journal of clinical microbiology.

[11]  Shuiping Yang,et al.  Development of extractive electrospray ionization ion trap mass spectrometry for in vivo breath analysis. , 2009, The Analyst.

[12]  H. Bean,et al.  Characterizing Bacterial Volatiles using Secondary Electrospray Ionization Mass Spectrometry (SESI-MS) , 2011, Journal of visualized experiments : JoVE.

[13]  S. Cristoni,et al.  Secondary electrospray ionization-mass spectrometry: breath study on a control group , 2011, Journal of breath research.

[14]  W. Cao,et al.  Current Status of Methods and Techniques for Breath Analysis , 2007 .

[15]  J. Greenman,et al.  Microbial volatile compounds in health and disease conditions , 2012, Journal of breath research.

[16]  David R Murdoch,et al.  Detection of volatile metabolites produced by bacterial growth in blood culture media by selected ion flow tube mass spectrometry (SIFT-MS). , 2006, Journal of microbiological methods.

[17]  Malina K. Storer,et al.  Analysis of biogenic volatile organic compounds in human health and disease , 2011 .

[18]  Q. Jöbsis,et al.  Biomarkers in exhaled breath condensate indicate presence and severity of cystic fibrosis in children , 2008, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[19]  Bogusław Buszewski,et al.  Determination of volatile organic compounds in human breath for Helicobacter pylori detection by SPME-GC/MS. , 2011, Biomedical chromatography : BMC.

[20]  Lauren E. Manning,et al.  The scent of Mycobacterium tuberculosis--part II breath. , 2009, Tuberculosis.

[21]  Maria L. Gennaro,et al.  Changes in energy metabolism of Mycobacterium tuberculosis in mouse lung and under in vitro conditions affecting aerobic respiration , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Anton Amann,et al.  Molecular analysis of volatile metabolites released specifically by staphylococcus aureus and pseudomonas aeruginosa , 2012, BMC Microbiology.

[23]  David Smith,et al.  An investigation of suitable bag materials for the collection and storage of breath samples containing hydrogen cyanide , 2012, Journal of breath research.

[24]  David Smith,et al.  Hydrogen cyanide as a biomarker for Pseudomonas aeruginosa in the breath of children with cystic fibrosis , 2009, Pediatric pulmonology.

[25]  Conrad Bessant,et al.  Prospects for Clinical Application of Electronic-Nose Technology to Early Detection of Mycobacterium tuberculosis in Culture and Sputum , 2006, Journal of Clinical Microbiology.

[26]  Jiangjiang Zhu,et al.  Fast Detection of Volatile Organic Compounds from Bacterial Cultures by Secondary Electrospray Ionization-Mass Spectrometry , 2010, Journal of Clinical Microbiology.

[27]  D. Murdoch,et al.  The rapid evaluation of bacterial growth in blood cultures by selected ion flow tube-mass spectrometry (SIFT-MS) and comparison with the BacT/ALERT automated blood culture system. , 2006, Journal of microbiological methods.

[28]  C. Mayhew,et al.  A preliminary comparison of volatile organic compounds in the headspace of cultures of Staphylococcus aureus grown in nutrient, dextrose and brain heart bovine broths measured using a proton transfer reaction mass spectrometer , 2009, Journal of breath research.

[29]  J. Greenman,et al.  Multivariate analysis of bacterial volatile compound profiles for discrimination between selected species and strains in vitro. , 2011, Journal of microbiological methods.

[30]  J. Gordon,et al.  Molecular analysis of commensal host-microbial relationships in the intestine. , 2001, Science.

[31]  Heather D. Bean,et al.  Bacterial volatile discovery using solid phase microextraction and comprehensive two-dimensional gas chromatography-time-of-flight mass spectrometry. , 2012, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[32]  V. Shestivska,et al.  Quantification of methyl thiocyanate in the headspace of Pseudomonas aeruginosa cultures and in the breath of cystic fibrosis patients by selected ion flow tube mass spectrometry. , 2011, Rapid communications in mass spectrometry : RCM.

[33]  V. Shestivska,et al.  Variability in the concentrations of volatile metabolites emitted by genotypically different strains of Pseudomonas aeruginosa , 2012, Journal of applied microbiology.

[34]  M. Epton,et al.  Developments in novel breath tests for bacterial and fungal pulmonary infection. , 2012, Current opinion in pulmonary medicine.

[35]  M. Phillips,et al.  Variation in volatile organic compounds in the breath of normal humans. , 1999, Journal of chromatography. B, Biomedical sciences and applications.

[36]  G. Gasbarrini.  Breath tests. , 2004, European review for medical and pharmacological sciences.

[37]  M. Phillips,et al.  Breath tests in medicine. , 1992, Scientific American.

[38]  David Smith,et al.  The concentration distributions of some metabolites in the exhaled breath of young adults , 2007, Journal of breath research.

[39]  David Smith,et al.  Detection of volatile compounds emitted by Pseudomonas aeruginosa using selected ion flow tube mass spectrometry , 2005, Pediatric pulmonology.

[40]  J. Labows,et al.  Volatiles of Pseudomonas aeruginosa and related species by automated headspace concentration--gas chromatography. , 1985, Canadian journal of microbiology.

[41]  S. Suh,et al.  Adaptations of Pseudomonas aeruginosa to the Cystic Fibrosis Lung Environment Can Include Deregulation of zwf, Encoding Glucose-6-Phosphate Dehydrogenase , 2005, Journal of bacteriology.

[42]  J. Pearson,et al.  Potential sources of 2-aminoacetophenone to confound the Pseudomonas aeruginosa breath test, including analysis of a food challenge study , 2011, Journal of breath research.

[43]  Ida A. Casalinuovo,et al.  Application of Electronic Noses for Disease Diagnosis and Food Spoilage Detection , 2006, Sensors (Basel, Switzerland).

[44]  W. Vautz,et al.  Ion mobility spectrometry for microbial volatile organic compounds: a new identification tool for human pathogenic bacteria , 2012, Applied Microbiology and Biotechnology.

[45]  A. Chakrabarty,et al.  Genetic mapping of chromosomal determinants for the production of the exopolysaccharide alginate in a Pseudomonas aeruginosa cystic fibrosis isolate , 1981, Infection and immunity.

[46]  David Smith,et al.  Selected ion flow tube, SIFT, studies of the reactions of H3O+, NO+ and O2+ with compounds released by Pseudomonas and related bacteria , 2004 .

[47]  Q. Jöbsis,et al.  Metabolomics of Volatile Organic Compounds in Cystic Fibrosis Patients and Controls , 2010, Pediatric Research.

[48]  G. Hanna,et al.  Variation in the levels of volatile trace gases within three hospital environments: implications for clinical breath testing , 2010, Journal of breath research.

[49]  P. Martínez-Lozano,et al.  Secondary electrospray ionization (SESI) of ambient vapors for explosive detection at concentrations below parts per trillion , 2009, Journal of the American Society for Mass Spectrometry.

[50]  S. Chambers,et al.  The scent of Mycobacterium tuberculosis. , 2008, Tuberculosis.

[51]  Lauren Ancel Meyers,et al.  Fighting change with change: adaptive variation in an uncertain world , 2002 .

[52]  P. Corris,et al.  Volatile biomarkers of Pseudomonas aeruginosa in cystic fibrosis and noncystic fibrosis bronchiectasis , 2011, Letters in applied microbiology.

[53]  L. Halonen,et al.  Background levels and diurnal variations of hydrogen cyanide in breath and emitted from skin , 2011, Journal of breath research.

[54]  Naresh Magan,et al.  Detection of Mycobacterium tuberculosis (TB) in vitro and in situ using an electronic nose in combination with a neural network system. , 2004, Biosensors & bioelectronics.

[55]  A. Szpiro,et al.  Pathogen Detection Using Headspace Analysis , 2004 .

[56]  N. Ratcliffe,et al.  The importance of methane breath testing: a review , 2013, Journal of breath research.

[57]  William J Tyler,et al.  A quantitative overview of biophysical forces impinging on neural function , 2013, Physical biology.

[58]  J. Leyden,et al.  Headspace analysis of volatile metabolites of Pseudomonas aeruginosa and related species by gas chromatography-mass spectrometry , 1980, Journal of clinical microbiology.

[59]  R. Laing,et al.  2-Aminoacetophenone as a potential breath biomarker for Pseudomonas aeruginosa in the cystic fibrosis lung , 2010, BMC pulmonary medicine.

[60]  P. Martínez-Lozano,et al.  Electrospray ionization of volatiles in breath , 2007 .

[61]  Alan Gelperin,et al.  Volatile compounds characteristic of sinus-related bacteria and infected sinus mucus: analysis by solid-phase microextraction and gas chromatography-mass spectrometry. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.